CU-GENES (Genetic Engagement, Education, and Screening)
Inclusion Criteria:
• Over the age of 25
• At least one grandparent of Jewish ancestry OR be of Spanish ancestry with roots in the San Luis Valley
• No prior genetic testing
• No personal history of bone marrow transplants or blood cancers
• Currently live in Colorado OR New Mexico
...
Protocol #23-0584
|
The ROSIE Study
Two, in-person visits between 1-2 hours over approximately a 3-month period....
Protocol #23-1234
|
FONTANA: A Modular Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics,
and Preliminary Efficacy of Ascending Doses of AZD5335 Monotherapy and in Combination with Anti-cancer Agents in Participants with Solid Tumors
Protocol #23-2128
Location: CTRC Inpatient, University of Colorado Hospital
|
A phase I/II study of VLS-1488 (an oral KIF18A inhibitor) in subjects with advanced cancer
Protocol #23-1991
Location: CTRC Inpatient, University of Colorado Hospital
|
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects with Ovarian Cancer (NXP800-101; ENGOTGYN5/ NCRI/NXP800-101; GOG-3087)
Protocol #23-0966
Location: CTRC Inpatient, University of Colorado Hospital
|
An Open-Label Phase 1 Study to evaluate the safety and Efficacy of AB-1015 in Patients with Platinum-Resistant Epithelial Ovarian Cancer
Protocol #23-0956
Location: CTRC Inpatient, University of Colorado Hospital
|
A Phase 1b/2 Basket Study of ACR-368 as Monotherapy and in Combination with Gemcitabine in Adult Subjects with Platinum-Resistant Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma Based on Acrivon OncoSignature? Status
Protocol #23-0115
Location: CTRC Inpatient, University of Colorado Hospital
|
A PHASE 1/2, OPEN LABEL, DOSE ESCALATION AND EXPANSION STUDY OF TAC-001 IN PATIENTS WITH SELECT ADVANCED OR METASTATIC SOLID TUMORS
Protocol #22-1188
Location: CTRC Inpatient, University of Colorado Hospital
|
A PHASE 1b STUDY OF ZN-c3 IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN, PERITONEAL, OR FALLOPIAN TUBE CANCER
Protocol #22-0890
Location: CTRC Inpatient, Outpatient CTRC, University of Colorado Hospital
|
NRG-CC008: A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROC]
Protocol #20-2079
Location: Highlands Ranch Hospital, Memorial Hospital Central, Memorial Hospital North, University of Colorado Hospital
|
S1714: A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane Induced Peripheral Neuropathy in Cancer Patients
Protocol #19-2216
Location: Rocky Mountain Regional VA Medical Center
|
NRG-GY019: A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Protocol #19-2797
Location: University of Colorado Hospital
|
Post-Prandial Liver Glucose Metabolism in Polycystic Ovarian Syndrome (PCOS) and understanding Standard of Care Medications
Protocol #16-2399
Location: Outpatient CTRC, Outpatient CTRC, University of Colorado Hospital
|
